Ashok Bandaranayake

Title: Ashok Bandaranayake: Innovator in Antibody Technology

Introduction

Ashok Bandaranayake is a notable inventor based in Seattle, WA (US). He has made significant contributions to the field of biotechnology, particularly in the development of innovative antibody technologies. His work focuses on creating therapeutic solutions that target specific antigens, which can lead to advancements in cancer treatment.

Latest Patents

Bandaranayake holds a patent for "Anti-mesothelin antigen-binding molecules and uses thereof." This patent includes antibodies and polypeptides that specifically bind to mesothelin (MSLN). It also encompasses bispecific antibodies that can bind both MSLN and a T cell antigen, such as CD3. The patent outlines pharmaceutical compositions that include these antibodies, nucleic acids encoding them, expression vectors, and host cells for their production. Furthermore, it details methods for treating subjects using these antibodies.

Career Highlights

Throughout his career, Bandaranayake has demonstrated a commitment to advancing medical science through his innovative research. His work has the potential to impact the treatment of various cancers by providing targeted therapies that can improve patient outcomes. With 1 patent to his name, he continues to be a driving force in the field of antibody technology.

Collaborations

Some of his notable coworkers include Colin Correnti and Christopher Mehlin. Their collaborative efforts have contributed to the development of groundbreaking technologies in the field.

Conclusion

Ashok Bandaranayake is a distinguished inventor whose work in antibody technology is paving the way for new therapeutic approaches in cancer treatment. His innovative patent on anti-mesothelin antigen-binding molecules exemplifies his dedication to improving healthcare through scientific advancements.